Insmed | INSM - Profitto Lordo Sulle Vendite





Profitto Lordo Sulle Vendite Cambiamento Data
BioMarin Pharmaceutical USD 713.01M 81.81M 2025-12
Cytokinetics USD 17.76M 15.82M 2025-12
DBV Technologies USD 2.77M 33.21M 2025-09
Gilead Sciences USD 6.31B 106M 2025-12
Heron Therapeutics USD 29.47M 3.17M 2025-12
Insmed USD 217.69M 106.25M 2025-12
Novartis USD 10.82B 694M 2025-09
Regeneron Pharmaceuticals USD 3.3B 67M 2025-12
Sarepta Therapeutics USD 43.55M 204.36M 2025-12
Ultragenyx Pharmaceutical USD 178M 46.06M 2025-12
Vertex Pharmaceuticals USD 2.72B 62.4M 2025-12